BridgeBio Pharma, Inc. (BBIO) stock
Close on Nov 12, 2026Market cap $15.23BP/E –Yield –
BridgeBio Pharma statistics
74 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 23, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 14.49
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 2.39%
- 10.9%
- Shares Change (QoQ)
- 0.37%
- 0.48%
- Float
- 125M
- 49M
- Shares Held by Insiders
- 35.6%
- 12.1%
- Shares Held by Institutions
- 99.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 21M
- –
- Short Interest Change
- 4.24%
- -0.76%
- Short % of Float
- 16.6%
- 9.06%
- Short % of Shares Outstanding
- 10.7%
- 6.30%
- Days to Cover
- 7.06
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $93.42
- –
- 52-Week Low
- $62.50
- –
- 20-Day Moving Average
- $72.51
- –
- 50-Day Moving Average
- $69.92
- –
- 200-Day Moving Average
- $72.70
- –
- Average True Range (14)
- $2.79
- –
- Price Change (1 Week)
- 5.25%
- 1.51%
- Price Change (1 Month)
- 20.4%
- -2.37%
- Price Change (3 Months)
- -2.12%
- -21.1%
- Price Change (6 Months)
- 12.2%
- -22.8%
- Price Change (YTD)
- 2.20%
- -22.6%
- Price Change (1 Year)
- 17.4%
- -21.0%
- Price Change (3 Years)
- 184.0%
- -24.8%
- Price Change (5 Years)
- 63.3%
- -76.9%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 3M
- –
- Average Volume (90 Days)
- 3M
- –
- Relative Volume
- 0.64
- 0.80
- Relative Strength Index (14)
- 64.7
- 44.7
- Volatility (1 Year)
- 44.1%
- 80.2%
- Beta (5 Years)
- 1.11
- 1.07
MarginsIndustry
- EBITDA Margin
- -38.0%
- -27.7%
- FCF Margin
- -39.1%
- -8.85%
Returns on capitalIndustry
- Return on Capital Employed (ROCE)
- -30.7%
- -38.1%
Financial positionIndustry
- Current Ratio
- 2.09
- 3.31
- Quick Ratio
- 1.96
- 2.41
- Interest Coverage
- -7.13
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 167.3%
- 7.26%
- Revenue Growth (3Y CAGR)
- 86.3%
- 2.25%
- Revenue Growth (5Y CAGR)
- 127.4%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.60
- 0.40
- Inventory Turnover
- 1.27
- 2.73
- Revenue Per Employee
- $1.13M
- $429.38K
- Employee Count
- 834
- 75
- WACC
- 10.4%
- 10.0%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $1.54B
- $16.98M
- Net Cash Per Share
- $7.90
- $0.72
- Equity (Book Value)
- -$1.66B
- $52.68M
- Book Value Per Share
- -$8.53
- $1.50
- Tangible Book Value
- -$1.69B
- $26.74M
- Working Capital
- $1.07B
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$835.00K
- -$944.00K
- FCF Per Share
- -$1.90
- -$0.42
Dividends and yieldsIndustry
- FCF Yield
- -2.43%
- -9.44%
- Buyback Yield
- 1.66%
- -0.73%
- Shareholder Yield
- 1.66%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $51.11M
- $2.97M
Scores and fair valueIndustry
- Altman Z-Score
- 0.15
- 0.26
- Beneish M-Score
- 8.38
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BBIO | S&P 500 | Difference | BBIO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +18.9% | -2.7% | +21.6 pts | ||
| 3 months | -6.8% | -1.7% | −5.0 pts | ||
| Year to date | +2.2% | +11.9% | −9.7 pts | ||
| 1 year | +18.0% | +12.0% | +6.1 pts | ||
| 3 years | +188.5% | +78.2% | +110.3 pts | +42.3% | +21.2% |
| 5 years | +63.3% | +73.2% | −10.0 pts | +10.3% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
21M BBIO shares were sold short on Oct 30, 2026, up 4.2% from the previous report, or 16.62% of the shares available to trade. At recent volumes it would take 7.1 days to buy them back. Over the last 20 sessions, 54.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 20,846,164 | +4.2% | 2,952,343 | 7.1 |
| Oct 15, 2026 | 19,997,556 | +1.7% | 2,603,763 | 7.7 |
| Sep 30, 2026 | 19,671,292 | -8.7% | 3,364,995 | 5.8 |
| Sep 15, 2026 | 21,549,349 | -1.4% | 2,044,711 | 10.5 |
| Aug 31, 2026 | 21,845,899 | -6.3% | 1,954,275 | 11.2 |
| Aug 14, 2026 | 23,324,059 | -0.1% | 2,161,484 | 10.8 |
| Jul 31, 2026 | 23,342,623 | -9.4% | 2,029,913 | 11.5 |
| Jul 15, 2026 | 25,750,649 | +6.8% | 4,789,357 | 5.4 |
| Jun 30, 2026 | 24,102,938 | -5.2% | 5,343,347 | 4.5 |
| Jun 15, 2026 | 25,415,150 | +4.2% | 2,966,678 | 8.6 |
| May 29, 2026 | 24,391,359 | +0.9% | 2,541,695 | 9.6 |
| May 15, 2026 | 24,163,037 | +0.6% | 2,766,467 | 8.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?